leisure time -WSS

leisure time

author：explore 2025-09-03 12:05:44 - browse：11

David Sabatini at home — David Sabatini posed at his home in Cambridge in 2022. Craig F. Walker/Boston Globe

Former MIT and Whitehead Institute star biologist David Sabatini, who lost his lofty positions after being accused of violating sexual harassment policies in 2021, is rejoining the Boston scientific community as head of a research group at a new laboratory under the umbrella of a Czech-based scientific institute.

Sabatini, who has denied harassing anyone and filed litigation over the claims, has been working since last October in a senior research position at the Institute of Organic Chemistry and Biochemistry, in the Czech Republic capital of Prague, investigating scientific questions in the areas of cell growth and metabolism, similar to his past research at Whitehead.

The Czech institute, known as IOCB Prague, is realizing a long-held ambition to expand into the Boston biotech hub, confirmed the institute’s director, Jan Konvalinka.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare proposal to cover medical devices draws a mixed reaction
Next article： How to make the FDA’s new prescription one

WSS

FDA proposes changes to key medical devices approval pathway

How medical schools plan to diversify without affirmative action

Private equity could exacerbate cardiology's overuse problem, experts fear

Telehealth for opioid use disorder is lifesaving

New weight loss drugs vying to be the next Wegovy or Mounjaro

Abortion policy in the spotlight at Republican debate

leisure time

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

23andMe had bad news about my health. I wish a person had delivered it

How the first Native Hawaiian psychiatrist helped diversify medicine

Activists slam private health insurers over coverage restrictions

Roche's accidental data boosts hopes for anti

Duchenne breakthrough therapy leaves behind pioneering families

Study: Spinal cord stimulation helps patients with paralysis walk again

DIEP, the 'gold standard' of breast reconstruction, is under threat

Acelyrin, a rare IPO success, stumbles in its first big test

Wildfire smoke exposes gaps in outdoor worker protections

What to make of Biden’s latest efforts on cancer research

knowledge

California store owner shot dead in dispute over displaying Pride flag: Police

How to make over

Regeneron agrees to White House price limits on anti

Private equity could exacerbate cardiology's overuse problem, experts fear

California store owner shot dead in dispute over displaying Pride flag: Police

Former Pear Therapeutics executives start new VC firm

leisure time

entertainment

leisure time

focus